-
Thu18Oct2018Sat20Oct2018
-
Mon22Oct2018Wed24Oct2018
-
Tue23Oct2018Fri26Oct2018
-
Fri26Oct2018Sat27Oct2018
-
Sat10Nov2018Wed14Nov2018
-
Thu15Nov2018Fri16Nov2018
-
Wed05Dec2018Sat08Dec2018
-
Wed05Dec2018Sat08Dec2018
Latest News
Rivaroxaban gets FDA approval for treatment in CAD or PAD
Rivaroxaban, brand name Xarelto (Janssen), has received approval by the US Food and Drug Administration (FDA) to reduce the risk of major cardiovascular (CV)...
Features
ADVERTORIAL: Tricuspid annular reduction using Edwards Cardioband (TM) Tricuspid Valve Reconstruction...
This content is only for readers outside of the USA
First real-world case experience with the Cardioband Tricuspid System by Marcel Weber, Jan-Malte Sinning, Nikos...
The US should follow Europe’s lead and change guidelines on embolic...
The revised European Society of Cardiology (ESC) myocardial revascularisation guidelines have downgraded the use of embolic protection devices during saphenous vein graft intervention from...
Videos
In this PCR video, David E Kandzari (Department of Interventional Cardiology, Piedmont Heart Institute, Atlanta, USA) speaks to Atul Pathak (National Institute of Health and Medical Research, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France) about the implications of the...
(Visited 28,687 times, 4 visits today)
